Physician profile
Hunter Belanger
NPI 1225778251
$1,158.94
in general payments reported to CMS, 2019-2025
9 companies · $716 in 2025
The $716 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $323 · 2024: $121 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $585.17 | 2023-2025 | Blueprint Patient Specific Instrumentation, Tornier Perform Reversed Glenoid, Tornier Perform Reversed Augmented Glenoid |
| Depuy Synthes Sales INC. | $162.34 | 2023-2025 | Lcp |
| Bioventus LLC | $141.39 | 2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Si-Bone, INC. | $120.87 | 2024 | |
| Illuminoss Medical, INC. | $80.47 | 2023 | Photodynamic Bone Stabilization Procedure Pack |
| Sanofi-Aventis U.S. LLC | $21.49 | 2023 | |
| Janssen Pharmaceuticals, INC | $17.13 | 2023 | Xarelto |
| Solventum Corporation | $17.12 | 2025 | V.A.C. Veraflo, Prevena |
| Mid-Atlantic Surgical Systems, LLC | $12.96 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hunter Belanger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.